2025-11-17T12:39:14-06:00 2024-12-31 410746749 CLIFTONLARSONALLEN LLP 950 N GLEBE ROAD SUITE 1200 ARLINGTON VA 22203 990 2024-01-01 521006053 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION ADVA 2027838700 1301 PENNSYLVANIA AVE NW 400 WASHINGTON DC 200042654 JENNIFER BREAREY CHIEF FINANCIAL OFFICER 2027838700 2025-11-16 1 1 ROBERT WILLIAMS P01345960 5712279500 2025-11-16 2024 2025-03-06 01:10:19Z ADVAMED SCOTT WHITAKER 1301 PENNSYLVANIA AVE NW 400 WASHINGTON DC 200042654 74308179 0 X WWW.ADVAMED.ORG X 1974 DE REPRESENT MEDICAL DIAGNOSTICS & DEVICE MANUFACTURERS ON REGULATORY & LEGISLATIVE ISSUES. 55 55 99 62 1865 0 611667 0 46928522 53886197 939808 808804 99000 81636 48578997 54776637 375965 479000 0 0 25828747 29964141 0 0 0 22404190 23977495 48608902 54420636 -29905 356001 42346557 41530606 25649849 24055089 16696708 17475517 ADVAMED ADVOCATES ON A GLOBAL BASIS FOR THE HIGHEST ETHICAL STANDARDS, TIMELY PATIENT ACCESS TO SAFE AND EFFECTIVE MEDICAL TECHNOLOGIES, AND ECONOMIC POLICIES THAT REWARD VALUE CREATION. 0 0 ADVAMED'S GOVERNMENT AFFAIRS FUNCTION REPRESENTS THE INDUSTRY BEFORE STATE AND FEDERAL POLICYMAKERS, IN GOVERNOR'S OFFICES, STATE LEGISLATURES, THE UNITED STATES CONGRESS, AND RELEVANT FEDERAL AGENCIES. ADVAMED'S ADVOCACY STAFF AND OUTSIDE CONSULTANTS PROVIDE INFORMATION ON POLITICAL AND POLICY DEVELOPMENTS, AND PURSUE THE INDUSTRY'S AGENDA FOR A LEGAL, REGULATORY AND ECONOMIC ENVIRONMENT THAT ADVANCES HEALTH CARE BY ASSURING PATIENT ACCESS TO THE BENEFITS OF MEDICAL TECHNOLOGY. TAKING MEMBER COMPANY FEEDBACK FROM WORKING GROUPS AND COMMITTEES, ADVAMED STAFF PROVIDE CRITICAL INPUT TO REGULATORY AGENCIES LIKE FDA AND CMS ON REGULATIONS AND RULES THAT IMPACT THE ABILITY FOR PATIENTS TO RECEIVE TIMELY ACCESS TO LIFE CHANGING DEVICES PRODUCED BY ADVAMED MEMBERS. OUR CONSULTANTS IN JAPAN, CHINA, AND OTHER OVERSEAS MARKETS REPRESENT ADVAMED IN RAPIDLY EXPANDING OVERSEAS MARKETS AND ATTEND MEETINGS WITH GOVERNMENT OFFICIALS AND INDUSTRY COMMITTEE MEETINGS. THESE CONSULTANTS PROVIDE REAL-TIME INFORMATION AND AN INDUSTRY VOICE IN OVERSEAS MARKETS. 0 0 0 1 0 0 0 0 0 1 0 0 1 1 1 0 1 0 1 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 88 0 1 99 1 1 1 1 JA CH 0 0 0 0 1 0 X 55 55 0 0 0 0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 0 X JENNIFER BREAREY 2027838700 1301 PENNSYLVANIA AVE NW SUITE 400 WASHINGTON DC 20004 PETER ARDUINI CHAIR 1.00 X X 0 0 0 LISA EARNHARDT SECRETARY 1.00 X X 0 0 0 GEOFF MARTHA TREASURER 1.00 X X 0 0 0 ANDRE-MICHEL BALLESTER DIRECTOR 1.00 X 0 0 0 ANTOINETTE GAWIN DIRECTOR 1.00 X 0 0 0 BRADY SHIRLEY DIRECTOR 1.00 X 0 0 0 BRIAN BLASER DIRECTOR 1.00 X 0 0 0 BRIAN MILLER DIRECTOR 1.00 X 0 0 0 CARLTON ST BERNARD DIRECTOR 1.00 X 0 0 0 CHRISTOPHER SIMON DIRECTOR 1.00 X 0 0 0 DAN CARESTIO DIRECTOR 1.00 X 0 0 0 DAVID ENDICOTT DIRECTOR 1.00 X 0 0 0 DAVID FERGUSON DIRECTOR (UNTIL 11/2024) 1.00 X 0 0 0 DAVID PACITTI DIRECTOR 1.00 X 0 0 0 DEEPAK NATH DIRECTOR 1.00 X 0 0 0 DEVDATT KURDIKAR DIRECTOR 1.00 X 0 0 0 DONALD BOBO DIRECTOR 1.00 X 0 0 0 ERIC ZACHARIAS DIRECTOR (UNTIL 04/2024) 1.00 X 0 0 0 HOLLY SHEFFIELD DIRECTOR 1.00 X 0 0 0 IVAN TORNOS DIRECTOR 1.00 X 0 0 0 JAMES CLEMMER DIRECTOR 1.00 X 0 0 0 JAN DE WITTE DIRECTOR 1.00 X 0 0 0 JEAN-CLAUDE DUBACHER DIRECTOR 1.00 X 0 0 0 JEFF DILULLO DIRECTOR 1.00 X 0 0 0 JEFF MIRVISS DIRECTOR 1.00 X 0 0 0 JIM HOLLINGSHEAD DIRECTOR 1.00 X 0 0 0 JOAKIM WEIDEMANIS DIRECTOR (UNTIL 09/2024) 1.00 X 0 0 0 JONATHAN RENNERT DIRECTOR 1.00 X 0 0 0 JOSEPH DEVIVO DIRECTOR 1.00 X 0 0 0 JOSEPH VIRGILIO DIRECTOR 1.00 X 0 0 0 JOSEPH WOODY DIRECTOR (UNTIL 10/2024) 1.00 X 0 0 0 JULIANA ELSTAD DIRECTOR 1.00 X 0 0 0 JULIE SAWYER-MONTGOMERY DIRECTOR 1.00 X 0 0 0 JULIEN SAUVAGNARGUES DIRECTOR 1.00 X 0 0 0 KEVIN LOBO DIRECTOR 1.00 X 0 0 0 LIAM KELLY DIRECTOR 1.00 X 0 0 0 LISHAN AKLOG DIRECTOR 1.00 X 0 0 0 MANU VARMA DIRECTOR 1.00 X 0 0 0 MARTHA SHADAN DIRECTOR 1.00 X 0 0 0 MATTHEW SAUSE DIRECTOR 1.00 X 0 0 0 MAUREEN MULVIHILL DIRECTOR 1.00 X 0 0 0 MICHAEL FARRELL DIRECTOR 1.00 X 0 0 0 MICHAEL MINOGUE DIRECTOR (UNTIL 06/2024) 1.00 X 0 0 0 NACHO ABIA DIRECTOR (UNTIL 03/2024) 1.00 X 0 0 0 NADIM YARED DIRECTOR (UNTIL 04/2024) 1.00 X 0 0 0 NELSON MENDES DIRECTOR 1.00 X 0 0 0 NORMAN SCHWARTZ DIRECTOR 1.00 X 0 0 0 RICHARD FABIAN DIRECTOR 1.00 X 0 0 0 SONAL MATAI DIRECTOR 1.00 X 0 0 0 STEPHEN MACMILLAN DIRECTOR 1.00 X 0 0 0 STEPHEN MASON DIRECTOR 1.00 X 0 0 0 SVEN SCHMIDT DIRECTOR 1.00 X 0 0 0 THIERRY BERNARD DIRECTOR 1.00 X 0 0 0 THOMAS KAPFER DIRECTOR 1.00 X 0 0 0 THOMAS POLEN DIRECTOR 1.00 X 0 0 0 TIM SCHMID DIRECTOR 1.00 X 0 0 0 TIMOTHY DUGAN DIRECTOR 1.00 X 0 0 0 TODD POPE DIRECTOR 1.00 X 0 0 0 TOM EISIMINGER DIRECTOR 1.00 X 0 0 0 TRACY MACNEAL DIRECTOR 1.00 X 0 0 0 VENK VARADAN DIRECTOR 1.00 X 0 0 0 VLADIMIR MAKATSARIA DIRECTOR 1.00 X 0 0 0 CHRISTOPHER L WHITE GENERAL COUNSEL & CHIEF POLICY OFF. 40.00 X 1073684 0 75332 JENNIFER BREAREY CHIEF FINANCIAL & OPERATING OFFICER 40.00 X 663348 0 75332 SCOTT WHITAKER PRESIDENT & CHIEF EXECUTIVE OFFICER 40.00 X 2386379 0 79342 GREG CRIST CHIEF ADVOCACY OFF. AND HEAD OF EXT. AFFAIR 40.00 X 807421 0 76342 ASHLEY MILLER EVP, GLOBAL STRATEGY & ANALYS 40.00 X 440710 0 43305 JANET TRUNZO SR ADVISOR TO THE PRES. & SR EXEC. 40.00 X 665656 0 52323 KIMBERLY ZIMMERMAN SENIOR VP, HEAD OF FEDERAL GOV. 40.00 X 471145 0 76342 RAYMOND BRISCUSO JR EXECUTIVE VP, CONFERENCES & EVENTS 40.00 X 559705 0 76265 ZACHARY ROTHSTEIN EXECUTIVE DIRECTOR, ADVAMEDDX 40.00 X 437064 0 76299 7505112 0 630882 79 0 1 0 FREEMAN EXPOSITIONS LLC PO BOX 734596 DALLAS TX 75373 GENERAL SERVICES FOR ANNUAL CONFERENCE 672023 FREEMAN DECORATING CO PO BOX 734596 DALLAS TX 75373 GENERAL SERVICES FOR ANNUAL CONFERENCE 655617 PROJECTION VIDEO SERVICES INC 5803 ROLLING RD STE 200 SPRINGFIELD VA 22152 AV SERVICES FOR ANNUAL CONFERENCE 644737 NARRATIVE STRATEGIES LLC 1400 L STREET NW SUITE 500 WASHINGTON DC 20005 GENERAL CONSULTING AND PR SERVICES 600831 AKIN GUMP STRAUSS HAUER & FELD LLP 2001 K STREET NW WASHINGTON DC 20006 CONGRESSIONAL ADVOCACY AND LEGAL SERVICE 551625 53 MEMBERSHIP DUES 900099 41952551 41952551 MEETINGS & SEMINARS 611430 7567549 7567549 ASSESSMENTS 900099 4366097 4366097 53886197 703840 703840 79771 79771 19636506 19529782 1760 106724 -1760 104964 104964 JOB BOARD REVENUE 900099 1865 1865 1865 54776637 53886197 1865 888575 X 479000 5237178 20100916 1481598 1758893 1385556 1112041 77769 3795584 7732360 4997 1218011 385863 2296634 933233 4874696 644022 143390 DUES AND SUBSCRIPTIONS 544966 TRAINING 85494 128435 54420636 22120542 22615910 1533910 1732165 1032098 1120916 3946105 1990196 2415820 1955909 1449796 1687344 2658426 2581490 11135965 9836872 42346557 41530606 7683672 8854894 1180864 931195 16785313 14269000 25649849 24055089 X 16696708 17475517 16696708 17475517 42346557 41530606 X 356001 392148 30660 X 0 1 X 1 0 0 0 0 0 0 1 42363249 4531747 1861493 6393240 6381935 11305 517999 155313 362686 1721438 860618 860820 1706668 974265 732403 1955909 INTERCOMPANY RECEIVABLE 109271 RIGHT OF USE ASSET 9727601 9836872 DEFERRED COMPENSATION 2454317 DEFERRED ASSESSMENTS 458184 LEASE LIABILITY 11356499 14269000 X PART X, LINE 2: ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) HAS BEEN RECOGNIZED BY THE INTERNAL REVENUE SERVICE AS EXEMPT FROM U.S. INCOME TAXES UNDER SECTION 501(C)(6) OF THE INTERNAL REVENUE CODE (IRC). THE ASSOCIATION IS NOT EXEMPT FROM U.S. INCOME TAXES ON INCOME FROM ANY UNRELATED BUSINESS ACTIVITIES. ADVAMED COMPLIES WITH THE ACCOUNTING STANDARD ON ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES. MANAGEMENT EVALUATED ADVAMED'S TAX POSITIONS AND CONCLUDED THAT IT HAD TAKEN NO UNCERTAIN TAX POSITIONS THAT REQUIRE ADJUSTMENT TO THE CONSOLIDATED FINANCIAL STATEMENTS TO COMPLY WITH THE PROVISIONS OF THIS GUIDANCE. EAST ASIA AND THE PACIFIC 4 12 PROGRAM SERVICES CONSULTANT IN ASIA MEET WITH GOVERNMENT AND INDUSTRY OFFICIALS 1646409 EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 192091 EUROPE 0 5 PROGRAM SERVICES CONSULTANT IN EUROPE MEET WITH GOVERNMENT AND INDUSTRY OFFICIALS 380244 EUROPE 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 56214 CENTRAL AMERICA AND THE CARIBBEAN 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 4742 NORTH AMERICA 0 12 PROGRAM SERVICES CONSULTANT IN NORTH AMERICA MEET WITH GOVERNMENT AND INDUSTRY OFFICIALS 9494 NORTH AMERICA 0 0 PROGRAM SERVICES ANNUAL CONFERENCE SUPPORT 2099491 NORTH AMERICA 0 0 PROGRAM SERVICES TRAVEL TO ANNUAL CONFERENCE 69420 SOUTH AMERICA 0 3 PROGRAM SERVICES ALLIANCE WITH LOCAL ORGANIZATION TO SUPPORT COMMON ISSUES 305952 SOUTH AMERICA 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 25916 SOUTH ASIA 0 2 PROGRAM SERVICES CONSULTANTS IN INDIA MEET WITH GOVERNMENT AND INDUSTRY OFFICIALS 303051 SOUTH ASIA 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 3345 SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 244 4 29 0 5 4 34 4458105 638508 5096613 0 0 0 0 0 0 1 NATIONAL ITALIAN AMERICAN FOUNDATION INC 1860 19TH STREET NW WASHINGTON DC 20009 521071723 501(C)(3) 50000 0 N/A N/A PROGRAM SUPPORT AMERICAN CANCER SOCIETY CANCER ACTION NETWORK 655 15TH STREET NW SUITE 503 WASHINGTON DC 20005 522340031 501(C)(4) 45000 0 N/A N/A PROGRAM SUPPORT RESEARCHAMERICA 241 18TH STREET SOUTH STE 501 ARLINGTON VA 22202 521609875 501(C)(3) 35000 0 N/A N/A PROGRAM SUPPORT ALLIANCE FOR AGING RESEARCH 1700 K STREET NW STE 740 WASHINGTON DC 20006 541379174 501(C)(3) 35000 0 N/A N/A PROGRAM SUPPORT FOGARTY INSTITUTE FOR INNOVATION SOBRATO PAVILION 2495 HOSPITAL DRIVE SUITE 300 MOUNTAIN VIEW CA 94040 113800306 501(C)(3) 30000 0 N/A N/A PROGRAM SUPPORT MARCH OF DIMES INC 1550 CRYSTAL DRIVE SUITE 1300 ARLINGTON VA 22202 131846366 501(C)(3) 27500 0 N/A N/A PROGRAM SUPPORT ALZHEIMER'S IMPACT MOVEMENT (AIM) 225 N MICHIGAN AVENUE FLOOR 17 CHICAGO IL 60601 271961435 501(C)(4) 25000 0 N/A N/A PROGRAM SUPPORT ASSOCIATION OF BLACK CARDIOLOGISTS INC 2400 N STREET NW SUITE 200 WASHINGTON DC 20037 953959283 501(C)(3) 25000 0 N/A N/A PROGRAM SUPPORT BREAKTHROUGH T1D 200 VESEY STREET 28TH FLOOR NEW YORK NY 10281 231907729 501(C)(3) 25000 0 N/A N/A PROGRAM SUPPORT GEORGE MASON UNIVERSITY FOUNDATION INC 4400 UNIVERSITY DRIVE MS 1A3 FAIRFAX VA 22030 541603842 501(C)(3) 20000 0 N/A N/A PROGRAM SUPPORT WASHINGTON LEGAL FOUNDATION 2009 MASSACHUSETTS AVENUE NW WASHINGTON DC 20036 521071570 501(C)(3) 20000 0 N/A N/A PROGRAM SUPPORT NATIONAL KIDNEY FOUNDATION INC 30 EAST 33RD STREET NEW YORK NY 10016 131673104 501(C)(3) 15000 0 N/A N/A PROGRAM SUPPORT PREVENT CANCER FOUNDATION 1600 DUKE STREET SUITE 500 ALEXANDRIA VA 22314 521429544 501(C)(3) 12000 0 N/A N/A PROGRAM SUPPORT INTERNATIONAL CENTER FOR PROFESSIONAL DEVELOPMENT 27890 CLINTON KEITH ROAD STE D314 MURRIETA CA 92562 274244677 501(C)(3) 11000 0 N/A N/A PROGRAM SUPPORT NATIONAL WOMENS HEALTH RESOURCE CENTER INC PO BOX 336 MIDDLETOWN NJ 07748 521624846 501(C)(3) 10000 0 N/A N/A PROGRAM SUPPORT MEDTECH COLOR 4940 PASO ROBLES AVENUE 209 ENCINO CA 91316 830543603 501(C)(3) 10000 0 N/A N/A PROGRAM SUPPORT AMERICAN HEART ASSOCIATION 7272 GREENVILLE AVENUE DALLAS TX 75231 135613797 501(C)(3) 10000 0 N/A N/A PROGRAM SUPPORT MOONSHOT LEARNING 5 DAIRY FARM LANE SOUTHBOROUGH MA 01772 001452853 INDIVIDUAL/SOLE PROP 10000 0 N/A N/A PROGRAM SUPPORT SOCIETY FOR WOMENS HEALTH RESEARCH 1025 CONNECTICUT AVE NW STE 601 WASHINGTON DC 20036 521694732 501(C)(3) 10000 0 N/A N/A PROGRAM SUPPORT LUNGEVITY FOUNDATION 228 SOUTH WABASH AVENUE STE 700 CHICAGO IL 60604 364433410 501(C)(3) 10000 0 N/A N/A PROGRAM SUPPORT EVERYLIFE FOUNDATION 1012 14TH STREET NW STE 500 WASHINGTON DC 20005 264614274 501(C)(3) 10000 0 N/A N/A PROGRAM SUPPORT MEDTECHWOMEN 2179 16TH AVENUE SAN FRANCISCO CA 94116 461442104 501(C)(3) 7500 0 N/A N/A PROGRAM SUPPORT GLOBAL DOWN SYNDROME FOUNDATION 3239 E 2ND AVENUE DENVER CO 80206 264431001 501(C)(3) 6000 0 N/A N/A PROGRAM SUPPORT 20 3 PART I, LINE 2: ADVAMED BUDGETS ANNUALLY FOR CHARITABLE DONATIONS AND OTHER CHARITABLE GIVING THAT IS CLOSELY ALIGNED WITH ITS STRATEGIC PLAN AND MISSION. IN ADDITION, ADVAMED MAY IDENTIFY CAUSES THROUGHOUT THE YEAR THAT MAY REQUIRE REPURPOSING OF FUNDS FROM ANOTHER EXPENSE CATEGORY TO SUPPORT CERTAIN MEDICAL DEVICE ISSUES OR MEMBERSHIP INITIATIVES, ALL SUCH SPENDING IS PROCESSED THROUGH ADVAMED'S PURCHASE ORDER SYSTEM, WHICH REQUIRES SEVERAL LEVELS OF EXECUTIVE APPROVAL BEFORE ANY FUNDING IS MADE. X X 1 1 X X X X X 0 0 0 SCOTT WHITAKER PRESIDENT & CHIEF EXECUTIVE OFFICER 1417212 0 966845 0 2322 0 39792 0 39550 0 2465721 0 0 0 CHRISTOPHER L WHITE GENERAL COUNSEL & CHIEF POLICY OFF. 782163 0 287957 0 3564 0 39792 0 35540 0 1149016 0 0 0 GREG CRIST CHIEF ADVOCACY OFF. AND HEAD OF EXT. 585130 0 221049 0 1242 0 39792 0 36550 0 883763 0 0 0 JENNIFER BREAREY CHIEF FINANCIAL & OPERATING OFFICER 491290 0 171248 0 810 0 39792 0 35540 0 738680 0 0 0 JANET TRUNZO SR ADVISOR TO THE PRES. & SR EXEC. 577610 0 83102 0 4944 0 39792 0 12531 0 717979 0 0 0 RAYMOND BRISCUSO JR EXECUTIVE VP, CONFERENCES & EVENTS 490845 0 62002 0 6858 0 39792 0 36473 0 635970 0 0 0 KIMBERLY ZIMMERMAN SENIOR VP, HEAD OF FEDERAL GOV. 409494 0 61651 0 0 0 39792 0 36550 0 547487 0 0 0 ZACHARY ROTHSTEIN EXECUTIVE DIRECTOR, ADVAMEDDX 380364 0 56160 0 540 0 39792 0 36507 0 513363 0 0 0 ASHLEY MILLER EVP, GLOBAL STRATEGY & ANALYS 388768 0 50700 0 1242 0 39792 0 3513 0 484015 0 0 0 PART I, LINE 1A FIRST CLASS TRAVEL IS AUTHORIZED ONLY IN EXCEPTIONAL CIRCUMSTANCES, SUCH AS WHEN IT IS NECESSARY TO TAKE A SPECIFIC FLIGHT WHERE BUSINESS OR COACH CLASS IS NOT AVAILABLE, AND MUST FIRST HAVE PRIOR WRITTEN APPROVAL BY DEPARTMENT HEADS AND ADVAMED'S PRESIDENT. OTHER EXPENSES INCURRED BY THE TRAVELER FOR TRAVEL OUTSIDE THE DEFINITION OF A BUSINESS TRIP, INCLUDING EXPENSES FOR FAMILY MEMBERS TRAVELING WITH THE EMPLOYEE, ARE ALSO THE RESPONSIBILITY OF THE TRAVELER AND NOT ADVAMED. SUCH EXPENSES ARE KEPT SEPARATE FROM REIMBURSABLE BUSINESS EXPENDITURES. PERSONAL TRAVEL FOR FAMILY MEMBERS/FRIENDS MAY BE BOOKED THROUGH ADVAMED'S TRAVEL AGENCY BUT ARE IDENTIFIED SEPARATELY AND BILLED DIRECTLY TO THE EMPLOYEE. THE CEO OF ADVAMED MAY TRAVEL BUSINESS CLASS ON ALL INTERNATIONAL FLIGHTS AND FOR TRAVEL OVER THREE HOURS IN DURATION WHERE SUCH SEATING IS AVAILABLE. FIRST CLASS SEATING WILL BE REIMBURSED ON DOMESTIC FLIGHTS OVER THREE (3) HOURS IN DURATION IF BUSINESS CLASS SEATING IS NOT OFFERED ON THE FLIGHT. THE ASSOCIATION SHALL REIMBURSE TRAVEL EXPENSES FOR EXECUTIVE'S SPOUSE TO ASSOCIATION EVENTS WHEN ATTENDANCE IS REQUIRED FOR BUSINESS PURPOSES. TRAVEL BENEFITS ARE INCLUDED IN TAXABLE COMPENSATION. FORM 990, PART VI, SECTION A, LINE 1A THERE SHALL BE AN EXECUTIVE COMMITTEE, WHICH SHALL CONSIST OF THE PRESIDENT, ELECTED OFFICERS OF THE ASSOCIATION, THE IMMEDIATE PAST CHAIR, THE ADVAMED-DX CHAIR, THE ADVAMED ACCEL CHAIR, THE BOARD TECHNOLOGY AND REGULATION COMMITTEE CHAIR, THE BOARD PAYMENT AND HEALTH CARE DELIVERY POLICY COMMITTEE CHAIR, THE INTERNATIONAL BOARD COMMITTEE CHAIR AND NOT FEWER THAN THREE NOR MORE THAN EIGHT MEMBERS OF THE BOARD OF DIRECTORS AT LARGE, WHO SHALL BE ELECTED TO THAT POSITION, FOR A PERIOD OF ONE YEAR AND THEREAFTER UNTIL A SUCCESSOR SHALL HAVE BEEN DULY ELECTED AND QUALIFIED, BY A MAJORITY OF THE ENTIRE BOARD OF DIRECTORS ANNUALLY. THE CHAIR SHALL ACT AS CHAIR OF THE EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE SHALL PERFORM SUCH DUTIES AS MAY BE DELEGATED TO IT BY THE BOARD OF DIRECTORS, AND MAY FURTHER ACT FOR AND ON BEHALF OF THE BOARD OF DIRECTORS BETWEEN MEETINGS OF THE BOARD OF DIRECTORS, PROVIDED THAT ALL SUCH ACTS SHALL BE FULLY REPORTED TO THE BOARD OF DIRECTORS AT OR BEFORE ITS NEXT MEETING FOR ITS REVIEW AND APPROPRIATE ACTION, IF REQUIRED OR DEEMED NECESSARY. FORM 990, PART VI, SECTION A, LINE 6 ANY FIRM OR CORPORATION WHICH, THROUGH ITSELF OR THROUGH ANY OF ITS SUBSIDIARIES OR DIVISIONS, IS SIGNIFICANTLY ENGAGED IN THE MANUFACTURE OF AND/OR THE RESEARCH WITH THE INTENT TO MANUFACTURE MEDICAL DEVICES, DIAGNOSTIC PRODUCTS AND/OR HEALTH CARE INFORMATION SYSTEMS WITHIN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS, SHALL BE ELIGIBLE FOR ACTIVE MEMBERSHIP. FORM 990, PART VI, SECTION A, LINE 7A EACH ACTIVE MEMBER IN GOOD STANDING SHALL BE ENTITLED TO ONE VOTE ON ANY QUESTION COMING BEFORE THE GENERAL MEMBERSHIP, INCLUDING THE ELECTION OF ONE THIRD OF THE BOARD OF DIRECTORS ANNUALLY. THE BOARD NOMINATING AND GOVERNANCE COMMITTEE PRESENTS A PROPOSED SLATE OF DIRECTORS ANNUALLY TO THE MEMBERSHIP FOR VOTE. EACH ACTIVE MEMBER SHALL, IN WRITING, DESIGNATE ITS OFFICIAL REPRESENTATIVE TO VOTE AND REPRESENT THAT MEMBER IN ALL OF THE AFFAIRS OF THE ASSOCIATION, INCLUDING THE HOLDING OF OFFICE. FORM 990, PART VI, SECTION A, LINE 7B EACH ACTIVE MEMBER IN GOOD STANDING SHALL BE ENTITLED TO ONE VOTE ON ANY QUESTION COMING BEFORE THE GENERAL MEMBERSHIP. EACH ACTIVE MEMBER SHALL, IN WRITING, DESIGNATE ITS OFFICIAL REPRESENTATIVE TO VOTE AND REPRESENT THAT MEMBER IN ALL OF THE AFFAIRS OF THE ASSOCIATION, INCLUDING THE HOLDING OF OFFICE. SUCH OFFICIAL REPRESENTATIVE SHALL BE THE CHIEF EXECUTIVE OFFICER OR CHIEF OPERATING OFFICER OF THE MEMBER OR SUCH OTHER SENIOR OPERATING OFFICER AS THE CHIEF EXECUTIVE OFFICER MAY DESIGNATE. FORM 990, PART VI, SECTION B, LINE 11B ADVAMED'S CHIEF FINANCIAL & OPERATING OFFICER AND VP FINANCE/CONTROLLER PERFORM AN IN-DEPTH REVIEW OF THE DRAFT 990. THE GENERAL COUNSEL REVIEWS THE FINAL DRAFT PRIOR TO SUBMITTING TO THE FINANCE, AUDIT AND COMPENSATION COMMITTEE (FAC). UPON THE FAC'S REVIEW THE 990 IS SUBMITTED TO THE FULL BOARD FOR THEIR REVIEW. PROVIDED NO CONCERNS ARE RAISED PRIOR TO THE END OF THE REVIEW PERIOD, THE 990 IS THEN FINALIZED AND SUBMITTED TO THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C ADVAMED HAS IN PLACE A CONFLICT OF INTEREST POLICY THAT IS MONITORED REGULARLY. EXCERPTS FROM THE POLICY RELATED TO THIS QUESTION ARE SHOWN BELOW: THE CONFLICT OF INTEREST POLICY OF ADVAMED: (1) DEFINES CONFLICTS OF INTEREST; (2) IDENTIFIES CLASSES OF INDIVIDUALS WITHIN THE ASSOCIATION COVERED BY THIS POLICY; (3) FACILITATES DISCLOSURE OF INFORMATION THAT MAY HELP IDENTIFY CONFLICTS OF INTEREST; AND (4) SPECIFIES PROCEDURES TO BE FOLLOWED IN MANAGING CONFLICTS OF INTEREST. 1. A CONFLICT OF INTEREST ARISES WHEN A PERSON IN A POSITION OF AUTHORITY OVER THE ASSOCIATION MAY BENEFIT FINANCIALLY FROM A DECISION HE OR SHE COULD MAKE IN THAT CAPACITY, INCLUDING INDIRECT BENEFITS SUCH AS TO FAMILY MEMBERS OR BUSINESSES WITH WHICH THE PERSON IS CLOSELY ASSOCIATED. ADVAMED'S POLICY IS FOCUSED UPON MATERIAL FINANCIAL INTEREST OF, OR BENEFIT TO, SUCH PERSONS. 2. PERSONS COVERED BY THIS POLICY ARE THE ASSOCIATION'S STAFF, OFFICERS, DIRECTORS, AND CHIEF EXECUTIVE OFFICER. 3. PERSONS COVERED BY THIS POLICY ANNUALLY DISCLOSE TO THE GENERAL COUNSEL ON A FORM PROVIDED BY THE ASSOCIATION THEIR INTERESTS THAT COULD GIVE RISE TO CONFLICTS OF INTEREST, SUBSTANTIAL BUSINESS OR INVESTMENT HOLDINGS, AND OTHER TRANSACTIONS OR AFFILIATIONS WITH BUSINESSES AND OTHER ORGANIZATIONS OR THOSE OF FAMILY MEMBERS. 4. FOR EACH INTEREST DISCLOSED TO THE GENERAL COUNSEL, THE GENERAL COUNSEL WILL DETERMINE WHETHER TO: (A) TAKE NO ACTION; (B) ASSURE FULL DISCLOSURE TO THE BOARD OF DIRECTORS AND OTHER INDIVIDUALS COVERED BY THIS POLICY; (C) ASK THE PERSON TO RECUSE FROM PARTICIPATION IN RELATED DISCUSSIONS OR DECISIONS WITHIN THE ASSOCIATION; OR (D) ASK THE PERSON TO RESIGN FROM HIS OR HER POSITION IN THE ASSOCIATION OR, IF THE PERSON REFUSES TO RESIGN, BECOME SUBJECT TO POSSIBLE REMOVAL IN ACCORDANCE WITH THE ASSOCIATION'S REMOVAL PROCEDURES. THE ASSOCIATION'S OFFICERS WILL MONITOR PROPOSED OR ONGOING TRANSACTIONS FOR CONFLICTS OF INTEREST AND DISCLOSE THEM TO THE CHAIRMAN OF THE BOARD OF DIRECTORS IN ORDER TO DEAL WITH POTENTIAL OR ACTUAL CONFLICTS, WHETHER DISCOVERED BEFORE OR AFTER THE TRANSACTION HAS OCCURRED. INTERESTS IN MEMBER COMPANIES: AT TIMES, ADVAMED STAFF AND/OR DIRECTORS MAY BE AWARE OF THE SIGNIFICANT AMOUNT OF INTEREST GENERATED IN CONNECTION WITH NEW PRODUCT DEVELOPMENT, SALES AND PROFITS, PRODUCT REGULATORY STATUS, AND ACQUISITIONS IN THE HEALTH CARE TECHNOLOGY INDUSTRY, THUS, ANYONE IN POSSESSION OF MATERIAL INFORMATION NOT GENERALLY AVAILABLE TO THE INVESTING PUBLIC MUST, IN ORDER TO COMPLY WITH THIS POLICY, EITHER DISCLOSE THAT KNOWLEDGE OR REFRAIN FROM TRADING IN THE STOCK. IN ADDITION, THE PURCHASE OF STOCK IN MEMBER COMPANIES CAN LEAD TO THE APPEARANCE THAT A MEMBER OF THE STAFF AND/OR BOARD OF DIRECTORS IS FAVORING THE INTERESTS OF THAT COMPANY BECAUSE OF SUCH FINANCIAL INTEREST. EVEN IF THERE IS NO ACTUAL CONFLICT OF INTEREST, THE APPEARANCE OF IMPROPRIETY MUST BE AVOIDED. NO EMPLOYEE OF THE ASSOCIATION OR MEMBER OF ITS BOARD OF DIRECTORS, EITHER IN HIS OR HER OWN NAME, OR IN THE NAME OF HIS OR HER SPOUSE OR CHILDREN, MAY PURCHASE STOCK IN ANY MEMBER COMPANY WITHOUT ADVISING THE ASSOCIATION PRESIDENT OF SUCH OWNERSHIP OR CONTEMPLATED OWNERSHIP. IN 2010, ADVAMED REQUIRED EMPLOYEES AND DIRECTORS TO SUBMIT AN ANNUAL FINANCIAL DISCLOSURE STATEMENT TO THE GENERAL COUNSEL REGARDING HOLDINGS IN MEMBER COMPANIES. AFTER REVIEW OF THE COMPLETED FORMS BY THE GENERAL COUNSEL, POTENTIAL CONFLICTS ARE REPORTED TO THE PRESIDENT, WHO REPORTS ANY SUCH DISCLOSURES TO THE CHAIRMAN OF THE BOARD OF DIRECTORS. INTEREST IN ENTITIES DOING BUSINESS WITH ADVAMED: IN THE COURSE OF ITS DAY-TO-DAY OPERATIONS, ADVAMED CONTRACTS WITH NUMEROUS FIRMS THAT PROVIDE GOODS AND SERVICES. IT IS IMPORTANT THAT THESE FIRMS ARE CHOSEN FOR BUSINESS PURPOSES AND NOT BECAUSE THEY ARE INAPPROPRIATELY FAVORED BY ADVAMED EMPLOYEES OR DIRECTORS WHO MAY HAVE A FINANCIAL INTEREST IN PARTICULAR TRANSACTIONS. ACCORDINGLY, ADVAMED EMPLOYEES AND DIRECTORS MUST DISCLOSE, ON AN ONGOING BASIS, ANY FINANCIAL INTEREST IN A COMPANY WITH WHICH ADVAMED CONTRACTS, OR IS CONSIDERING. FORM 990, PART VI, SECTION B, LINE 15 THE PROCESS INCLUDES ALL OF THESE ELEMENTS: (1) REVIEW AND APPROVAL BY THE COMPENSATION SUBCOMMITTEE OF THE FINANCE, AUDIT AND COMPENSATION COMMITTEE OF THE ASSOCIATION; (2) USE OF DATA AS TO COMPARABLE COMPENSATION; AND (3) CONTEMPORANEOUS DOCUMENTATION AND RECORDKEEPING. 1. REVIEW AND APPROVAL: THE COMPENSATION OF THE PERSON IS REVIEWED AND APPROVED BY THE BOARD COMMITTEE ON FINANCE, AUDIT AND COMPENSATION OF THE ASSOCIATION, PROVIDED THAT PERSONS WITH CONFLICTS OF INTEREST WITH RESPECT TO THE COMPENSATION ARRANGEMENT AT ISSUE ARE NOT INVOLVED IN THIS REVIEW AND APPROVAL. 2. USE OF DATA AS TO COMPARABLE COMPENSATION: THE COMPENSATION OF THE PERSON IS REVIEWED AND APPROVED USING DATA AS TO COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS. 3. CONTEMPORANEOUS DOCUMENTATION AND RECORDKEEPING: THERE IS CONTEMPORANEOUS DOCUMENTATION AND RECORDKEEPING WITH RESPECT TO THE DELIBERATIONS AND DECISIONS REGARDING THE COMPENSATION ARRANGEMENT. THE PROCESS RECENTLY TOOK PLACE IN 2024. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S FINANCIAL STATEMENTS, CONFLICT OF INTEREST POLICY AND GOVERNING DOCUMENTS ARE AVAILABLE UPON REQUEST FOR THE SAME PERIOD OF DISCLOSURE AS SET FORTH IN SECTION 6104(D). FORM 990, PART IX, LINE 11G OTHER CONSULTING EXPENSE 7,660,291. PAYROLL PROCESSING FEE 72,069. FORM 990, PART XI, LINE 9: CHANGE IN EQUITY IN ADVAMED PURCHASING GROUP -13,258. GAIN/LOSS ON LEASE MODIFICATION 43,918. MEDTECH CONFERENCE PARTNERS LLC 1301 PENNSYLVANIA AVE SUITE 400 WASHINGTON DC 20004 364725626 TRADE SHOW DC 0 0 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION ADVANCED MEDICAL TECHNOLOGY ASSOCIATION PAC 1301 PENNSYLVANIA AVE STE 400 WASHINGTON DC 20004 522134566 POLITICAL ACTION COMMITTEE DC 527 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION 1 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION CA PAC 1301 PENNSYLVANIA AVE STE 400 WASHINGTON DC 20004 455309081 POLITICAL ACTION COMMITTEE DC 527 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION 1 ADVAMED PURCHASING GROUP INC 1301 PENNSYLVANIA AVE SUITE 400 WASHINGTON DC 20004 812264022 GROUP PURCHASING PROGRAM DC ADVANCED MEDICAL TECHNOLOGY ASSOCIATION C 19608 109271 1.00000 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1 0 1